Taragenyx is a biotechnology startup based in the United Kingdom, founded in 2010. The company specializes in the development of medical implants with a focus on regenerative medicine. By leveraging the combination of engineering and biology, Taragenyx aims to create innovative medical devices that facilitate the body's self-repair process. Their implants are designed to last longer, leading to faster healing for patients with minimal discomfort. In August 2015, Taragenyx secured a £644.27K Venture Round investment, with Scottish Enterprise and Lancaster Capital participating as the investors. This funding aligns with the company's vision of advancing regenerative medicine and enhancing the efficacy of medical implants. With a strong focus on innovation and patient well-being, Taragenyx presents an exciting opportunity for venture capitalists looking to support advancements in the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | £644.27K | 2 |
|
14 Aug 2015 |
| Grant | £83.33K | 1 |
|
01 Mar 2014 |
| Seed Round | £400.00K | 2 |
|
25 Mar 2013 |
No recent news or press coverage available for Taragenyx.
We care about your data, and we'd love to use cookies make your experience better.
